We are currently developing different 3D synthetic and hybrid hydrogels to imitate extracellular matrices of different healthy and diseased tissues, especially from the immune system, with the objectives to 1) elucidate cancer- and immunotherapy-related cellular mechanisms, 2) improve immune cell cultures, and 3) develop novel patient-derived organoids, to have a positive influence on cancer (immuno)therapy and related disciplines.